Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
Danny Sullivan
Contributing editor to Longevity Technology
Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Details last updated 10-Feb-2020
Articles written by Danny Sullivan
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025It uses blood tests to find early health risks and gives personalised advice
Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025Clinical trials are beginning, backed by major investors like Novo Holdings
Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Europe’s first 100m consumer health fund targets proactive care revolution
Longevity Technology - 18-Feb-2025naturalX backs startups reshaping wellness and prevention
Mair Therapeutics targets Parkinson’s with AI-driven drug discovery
Longevity Technology - 17-Feb-2025The Dutch startup is using ion channel research and advanced tech to develop new treatments
Junevity secures $10m to pioneer “cell reset” therapies for longevity
Longevity Technology - 13-Feb-2025Backed by AI and genetics, Junevity targets age-related diseases
Nucleus brings whole-genome health testing to the masses
Longevity Technology - 30-Jan-2025Cutting-edge DNA analysis provides affordable, real-time health insights
Neko Health secures $260m to revolutionize preventive care
Longevity Technology - 23-Jan-2025Full-body scans drive early detection as Neko expands globally
Arctic Therapeutics secures €26.5M to advance dementia drugs
Longevity Technology - 21-Jan-2025Early trials show reduced stroke risks and slower progression
AI startup raises $41M to build a universal biology research tool
Longevity Technology - 15-Jan-2025Company aims to predict diseases, design therapies, and revolutionise research
Nanomedicines to reduce invasive treatments for inflammatory diseases
Longevity Technology - 14-Jan-2025It holds potential for treating inflammation, cancer, ageing, and autoimmunity
Tenvie Therapeutics raises major funding to tackle age-related diseases
Longevity Technology - 10-Jan-2025Dual-action therapies tackling inflammation, metabolism, and neurodegeneration
General Proximity uses biological proximity to develop new medicines
Longevity Technology - 06-Jan-2025The company has raised $16 million from investors
Proton Intelligence raises funds to develop potassium monitoring for kidney disease
Longevity Technology - 30-Dec-2024Clinical trials have begun on patients with severe kidney disease
DeepLife secures $10M for AI-driven healthcare innovation using digital twins
Longevity Technology - 17-Dec-2024This breakthrough combines large biological datasets and advanced AI tools
Display all articles
